UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 73

Sortiert nach

European guidelines on the clinical management of HIV-1 tropism testing

The Lancet infectious diseases, 2011-05, Vol.11 (5), p.394-407

2011

Volltextzugriff (PDF)

Concordance between HIV‐1 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA

HIV medicine, 2011-10, Vol.12 (9), p.544-552

2011

Volltextzugriff (PDF)

Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants

BMC infectious diseases, 2015-11, Vol.15 (494), p.496-496, Article 496

2015

Volltextzugriff (PDF)

Impact of triplicate testing on HIV genotypic tropism prediction in routine clinical practice

Clinical microbiology and infection, 2012-06, Vol.18 (6), p.606-612

2012

Volltextzugriff (PDF)

Late presentation to HIV testing is overestimated when based on the consensus definition

HIV medicine, 2016-03, Vol.17 (3), p.231-234

2016

Volltextzugriff (PDF)

Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene

Antimicrobial Agents and Chemotherapy, 1997-02, Vol.41 (2), p.284-291

1997

Volltextzugriff (PDF)

O5 The expression profile of host restriction factors in different cohorts of HIV-1-infected patients

Journal of Virus Eradication, 2017-09, Vol.3, p.2

2017

Volltextzugriff (PDF)

Determinants of adherence in a cohort of Belgian HIV patients: a pilot study

Acta clinica belgica (English ed. Online), 2014-04, Vol.69 (2), p.111-115

2014

Volltextzugriff (PDF)

A21 HIV-1 sub-subtype F1 outbreak among MSM in Belgium

Virus evolution, 2017-03, Vol.3 (suppl_1)

2017

Volltextzugriff (PDF)

Exposure to HIV-1 during delivery and mother-to-child transmission

AIDS (London), 2000-10, Vol.14 (15), p.2341-2348

2000

Volltextzugriff (PDF)

Primary resistance to integrase strand-transfer inhibitors in Europe

Journal of antimicrobial chemotherapy, 2015-10, Vol.70 (10), p.2885-2888

2015

Volltextzugriff (PDF)

Maraviroc: perspectives for use in antiretroviral-naive HIV-1-infected patients

Journal of antimicrobial chemotherapy, 2009-06, Vol.63 (6), p.1087-1096

2009

Volltextzugriff (PDF)

Evaluation of proviral copy number and plasma RNA level as early indicators of progression in HIV-1 infection: correlation with virological and immunological markers of disease

AIDS (London), 1994-10, Vol.8 (10), p.1421-1427

1994

Volltextzugriff (PDF)

Piloting a surveillance system for HIV drug resistance in the European Union

Euro surveillance : bulletin européen sur les maladies transmissibles, 2019-05, Vol.24 (19), p.1

2019

Volltextzugriff (PDF)

The latent HIV-1 reservoir in patients undergoing HAART: an archive of pre-HAART drug resistance

Journal of antimicrobial chemotherapy, 2005-04, Vol.55 (4), p.410-412

2005

Volltextzugriff (PDF)

CXCR4-using HIV type 1 variants are more commonly found in peripheral blood mononuclear cell DNA than in plasma RNA

Journal of acquired immune deficiency syndromes (1999), 2009-02, Vol.50 (2), p.126

2009

Volltextzugriff (PDF)

Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

Nature (London), 1996-08, Vol.382 (6593), p.722-725

1996

Volltextzugriff (PDF)

Maraviroc: integration of a new antiretroviral drug class into clinical practice

Journal of antimicrobial chemotherapy, 2008-06, Vol.61 (6), p.1187-1190

2008

Volltextzugriff (PDF)

Polyfunctional CD4 super(+) T cell responses in HIV-1 -infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine

Vaccine, 2013-08, Vol.31 (36), p.3739-3746

2013

Volltextzugriff (PDF)

High prevalence of bevirimat resistance mutations in protease inhibitor-resistant HIV isolates

AIDS (London), 2010-03, Vol.24 (5), p.669-673

2010

Volltextzugriff (PDF)

The AIDS epidemic: the spread of a deadly disease in the biotech era

Journal of biological regulators and homeostatic agents, 2004-04, Vol.18 (2), p.178

2004

Volltextzugriff (PDF)

Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment

Journal of antimicrobial chemotherapy, 2011-02, Vol.66 (2), p.265-272

2011

Volltextzugriff (PDF)

Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype

AIDS (London), 1999-12, Vol.13 (18), p.2541-2546

1999

Volltextzugriff (PDF)

The subcellular localization of the neu protein in human normal and neoplastic cells

International journal of cancer, 1989-12, Vol.44 (6), p.969-974

1989

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(72)
Tagungsberichte
(1)

Sprache

Englisch
(73)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

European guidelines on the clinical management of HIV-1 tropism testing

Concordance between HIV‐1 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA

Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants

Impact of triplicate testing on HIV genotypic tropism prediction in routine clinical practice

Late presentation to HIV testing is overestimated when based on the consensus definition

Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene

O5 The expression profile of host restriction factors in different cohorts of HIV-1-infected patients

Determinants of adherence in a cohort of Belgian HIV patients: a pilot study

A21 HIV-1 sub-subtype F1 outbreak among MSM in Belgium

Exposure to HIV-1 during delivery and mother-to-child transmission

Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium

Primary resistance to integrase strand-transfer inhibitors in Europe

Maraviroc: perspectives for use in antiretroviral-naive HIV-1-infected patients

Evaluation of proviral copy number and plasma RNA level as early indicators of progression in HIV-1 infection: correlation with virological and immunological markers of disease

Piloting a surveillance system for HIV drug resistance in the European Union

The latent HIV-1 reservoir in patients undergoing HAART: an archive of pre-HAART drug resistance

CXCR4-using HIV type 1 variants are more commonly found in peripheral blood mononuclear cell DNA than in plasma RNA

Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

Maraviroc: integration of a new antiretroviral drug class into clinical practice

Polyfunctional CD4 super(+) T cell responses in HIV-1 -infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine

High prevalence of bevirimat resistance mutations in protease inhibitor-resistant HIV isolates

The AIDS epidemic: the spread of a deadly disease in the biotech era

Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment

Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype

The subcellular localization of the neu protein in human normal and neoplastic cells

Suchergebnisse filtern